PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
0.582
-0.023 (-3.82%)
Dec 20, 2024, 4:00 PM EST - Market closed
PAVmed Stock Forecast
PAVM's stock price has decreased by -85.3% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for PAVmed stock has a target of 19, which predicts an increase of 3,164.60% from the current stock price of 0.58.
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for PAVmed is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $21 → $19 | Strong Buy | Maintains | $21 → $19 | +3,164.60% | Dec 9, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $22 → $21 | Strong Buy | Maintains | $22 → $21 | +3,508.25% | Sep 10, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $8.61 | Hold | Reiterates | $8.61 | +1,379.38% | Aug 18, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades $25 → $9.23 | Buy → Hold | Downgrades | $25 → $9.23 | +1,485.91% | Jan 20, 2023 |
| Lake Street | Lake Street | Strong Buy Maintains $31 → $9.23 | Strong Buy | Maintains | $31 → $9.23 | +1,485.91% | Jan 18, 2023 |
Financial Forecast
Revenue This Year
3.75M
from 2.45M
Increased by 52.90%
Revenue Next Year
13.08M
from 3.75M
Increased by 248.84%
EPS This Year
-6.00
from -9.16
EPS Next Year
-1.48
from -6.00
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 5.3M | 39.7M | 105.6M | |||
| Avg | 3.7M | 13.1M | 52.3M | |||
| Low | 2.9M | 196,000 | 2.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 114.1% | 958.7% | 707.7% | |||
| Avg | 52.9% | 248.8% | 300.1% | |||
| Low | 19.9% | -94.8% | -85.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -6.17 | -1.22 | -0.41 |
| Avg | -6.00 | -1.48 | -0.52 |
| Low | -5.76 | -1.71 | -0.61 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.